Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study

References

• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219.
   PubMed Web of Science ®Google Scholar
• Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047–2060.
   PubMed Web of Science ®Google Scholar
• Tanskanen M, Peuralinna T, Polvikoski T, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232–239.
   PubMed Web of Science ®Google Scholar
• Damy T, Kristen AV, Suhr OB, et al. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS. ). Eur Heart J. 2019.
   PubMedGoogle Scholar
• Nakagawa M, Sekijima Y, Yazaki M, et al. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23:58–63.
   PubMed Web of Science ®Google Scholar
• Westermark P, Westermark GT, Suhr OB, et al. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014;119:223–228.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Hammarström P, Matsumura M, et al. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest. 2003;83:409–417.
   PubMed Web of Science ®Google Scholar
• Béquignon E, Guellich A, Barthier S, et al. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Amyloid. 2017;24:96–100.
   PubMed Web of Science ®Google Scholar
• Chadwick MA, Buckland JR, Mason P, et al. A rare case of dysphagia: hypopharyngeal amyloidosis masquerading as a post-cricoid tumour. J Laryngol Otol. 2002;116:54–56.
   PubMed Web of Science ®Google Scholar
• Grindle CR, Curry JM, Cantor JP, et al. Localized oropharyngeal amyloidosis. Ear Nose Throat J. 2011;90:220–222.
   PubMed Web of Science ®Google Scholar
• Bartels H, Dikkers FG, van der Wal JE, et al. Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann Otol Rhinol Laryngol. 2004;113:741–748.
   PubMed Web of Science ®Google Scholar
• Lewis JE, Olsen KD, Kurtin PJ, et al. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg. 1992;106:372–377.
   PubMed Web of Science ®Google Scholar
• Talbot AR. Laryngeal amyloidosis. J Laryngol Otol. 1990;104:147–149.
   PubMed Web of Science ®Google Scholar
• Motta M, Velonà G, Trojsi R, et al. Laryngeal amyloidosis: a case report. Acta Otorhinolaryngol Ital. 1996;16:455–459.
   PubMedGoogle Scholar
• Cowan AJ, Skinner M, Berk JL, et al. Macroglossia – not always AL amyloidosis. Amyloid. 2011;18:83–86.
   PubMed Web of Science ®Google Scholar
• Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387:2641–2654.
   PubMed Web of Science ®Google Scholar
• Bodez D, Ternacle J, Guellich A, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid. 2016;23:158–167.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Damy T, Fontana M, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39:2799–2806.
   PubMed Web of Science ®Google Scholar
• Jacobson BH, Johnson A, Grywalski C, et al. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol. 1997;6:66–70.
   Google Scholar
• De Bodt MS, Van de Heyning PH, Wuyts FL, et al. The perceptual evaluation of voice disorders. Acta Otorhinolaryngol Belg. 1996;50:283–291.
   PubMedGoogle Scholar
• Leslie P, Carding PN, Wilson JA. Investigation and management of chronic dysphagia. BMJ. 2003;326:433–436.
   PubMed Web of Science ®Google Scholar
• Berg AM, Troxler RF, Grillone G, et al. Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol. 1993;102:884–889.
   PubMed Web of Science ®Google Scholar
• Wixner J, Mundayat R, Karayal ON, et al. THAOS: gastrointestinal manifestations of transthyretin amyloidosis – common complications of a rare disease. Orphanet J Rare Dis. 2014;9:61.
   PubMed Web of Science ®Google Scholar
• Visser AC, Klein CJ. Wild-type TTR neuropathy with cardiomyopathy presenting with burning feet. Neurology. 2017;88:1101–1102.
   PubMed Web of Science ®Google Scholar
• Adams D, Cauquil C, Labeyrie C. Familial amyloid polyneuropathy. Curr Opin Neurol. 2017;30:481–489.
   PubMed Web of Science ®Google Scholar
• Conaghan P, Chung D, Vaughan R. Recurrent laryngeal nerve palsy associated with mediastinal amyloidosis. Thorax. 2000;55:436–437.
   PubMed Web of Science ®Google Scholar
• Brett M, Persey MR, Reilly MM, et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain. 1999;122:183–190.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–224.
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Amyloid infiltration of the levator palpebrae superioris muscle: case report. Ann Ophthalmol. 1983;15:610–613.
   PubMedGoogle Scholar
• Ezawa N, Katoh N, Oguchi K, et al. Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging. Eur J Nucl Med Mol Imaging. 2017;5:452–461.
   Google Scholar
• Jamet M-P, Gnemmi V, Hachulla É, et al. Distinctive patterns of transthyretin amyloid in salivary tissue: a clinicopathologic study of 92 patients with amyloid-containing minor salivary gland biopsies. Am J Surg Pathol. 2015;39:1035–1044.
   PubMed Web of Science ®Google Scholar
• Ehman EC, El-Sady MS, Kijewski MF, et al. Early detection of multiorgan light chain (AL) amyloidosis by whole body 18F-florbetapir PET/CT. J Nucl Med. 2019.
   Google Scholar
• Ternacle J, Bodez D, Guellich A, et al. Causes and consequences of longitudinal lv dysfunction assessed by 2d strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging. 2016;9:126–138.
   PubMed Web of Science ®Google Scholar
• Caccialanza R, Palladini G, Klersy C, et al. Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment. JPEN J Parenter Enteral Nutr. 2014;38:891–894.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59.
   PubMed Web of Science ®Google Scholar
• Ryu CH, Han S, Lee M-S, et al. Voice changes in elderly adults: prevalence and the effect of social, behavioral, and health status on voice quality. J Am Geriatr Soc. 2015;63:1608–1614.
   PubMed Web of Science ®Google Scholar
• Easterling CS, Robbins E. Dementia and dysphagia. Geriatr Nurs. 2008;29:275–285.
   PubMed Web of Science ®Google Scholar
• Golub JS, Chen P-H, Otto KJ, et al. Prevalence of perceived dysphonia in a geriatric population. J Am Geriatr Soc. 2006;54:1736–1739.
   PubMed Web of Science ®Google Scholar